Kate Rochlin

Insider Reports History

Entity
Individual
Location
In8 Bio, Inc., Empire State Building, Suite 5330, New York, New York
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kate Rochlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
IN8BIO, INC. Chief Operating Officer Common Stock 17.6K $18.1K $1.03 Dec 13, 2023 Direct
IN8BIO, INC. Chief Operating Officer Employee Stock Option (right to buy) 250K Sep 4, 2024 Direct
IN8BIO, INC. Chief Operating Officer Employee Stock Option (right to buy) 186K Feb 7, 2024 Direct
IN8BIO, INC. Chief Operating Officer Series A Warrants (right to buy) 12.3K Dec 13, 2023 Direct
IN8BIO, INC. Chief Operating Officer Series B Warrants (right to buy) 12.3K Dec 13, 2023 Direct

Insider Reports Filed by Kate Rochlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INAB IN8BIO, INC. Sep 4, 2024 1 $0 4 Sep 5, 2024 Chief Operating Officer
INAB IN8BIO, INC. Feb 7, 2024 1 $0 4 Feb 8, 2024 CHIEF OPERATING OFFICER
INAB IN8BIO, INC. Dec 13, 2023 3 $0 4 Dec 15, 2023 Chief Operating Officer
INAB IN8BIO, INC. Jun 21, 2023 1 $0 4 Jun 23, 2023 Chief Operating Officer
INAB IN8BIO, INC. Apr 14, 2023 1 $0 4 Apr 18, 2023 Chief Operating Officer
INAB IN8BIO, INC. Oct 21, 2022 1 $0 4 Oct 25, 2022 Chief Operating Officer
INAB IN8BIO, INC. Aug 16, 2022 1 $10K 4 Aug 18, 2022 Chief Operating Officer
INAB IN8BIO, INC. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Operating Officer
INAB IN8BIO, INC. Dec 1, 2021 0 $0 3 Dec 10, 2021 Chief Operating Officer